CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research

Home
Canada
Vancouver, BC
CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research

Revolutionizing the prevention, treatment, and management of STBBIs

The CTN+ prioritizes regional research capacity by fostering, developing, and supporting research teams in regions across Canada. These regional teams, which include researchers, community members, and Indigenous representation, champion the knowledge needs of those in their local communities. The focus on regional capacity and engagement is informed by the Network’s objective to uphold Indigenous rights and move towards truth and reconciliation, recognizing the power of research and knowledge mobilization to improve health equity across the country.

10/24/2025

With systems across Canada are struggling to provide timely and equitable access to health care services, we need to find solutions. Why not look to Australia? 🇦🇺

Dr. Jason Sutherland, Program Head of Health Services & Outcomes at Advancing Health, explains why:
https://bit.ly/43xaA86

10/23/2025

Nineteen new or renewed Canada Research Chairs have been awarded to McGill University, providing over $13 million in funding. Among the chairs whose research was funded was CTN+ National Director, Dr. Marina Klein. Her research is aimed at developing, implementing, and evaluating interventions to improve health outcomes for people living with HIV, viral hepatitis, and STBBIs.

Learn more about all the research funded:
https://bit.ly/48Exyhf

10/22/2025

"Doxycycline is needed for STBBI prevention, because the status quo just wasn't cutting it anymore," said Dr Troy Grennan, co-lead for the CTN+ BC & Yukon Regional Team.

Every health intervention has both its benefits and its drawbacks. This excellent video gives everyone a chance to watch subject matter experts weigh in with nuanced perspectives on the antibiotic doxycycline, and we highly recommend everyone check out both this video and the full playlist from STI & HIV 2025 World Congress.

10/21/2025

CAHR's New Investigator Forum will be taking place from April 14-16, 2026, in King City, Ontario.

Recognizing the unique challenges faced by early career researchers, this event is designed to support the professional development of those pursuing an academic career in the fields of infection and immunity.

Interested in attending? Then be sure to apply by November 18th!
https://bit.ly/3KUCAMA

10/20/2025

What if could be controlled without daily medication?

New research published in Nature Medicine from a Phase I clinical trial with CTN+ researcher Dr. Jean-Pierre Routy and the RI-MUHC Chronic Viral Illness Service team brings that possibility closer.

Learn more: https://bit.ly/4otd13T

10/17/2025

🤰A recent study conducted by researchers involved with the Canadian Perinatal HIV Surveillance Program investigated effects of the HIV drug bictegravir in infants exposed to this drug in the womb. The results were reassuring, finding no increased risk of birth defects among the 161 infants exposed to the drug over five years.

Read more:
https://bit.ly/47u5QT6

10/16/2025

Are you a young researcher ready to take your research to new heights?

Then you'll absolutely want to check out CAHR's Travel Awards. This program is designed to support the next generation of HIV researchers by helping attend conferences wand access professional development opportunities.
Learn more: https://bit.ly/4hdkYI0

10/15/2025

In the October issue of , Devan Nambiar, co-lead of the CTN+ Cure & Immunotherapies Think Tank, reflects on history, activism, and research in the context of love, loss, family, and more. He says, "Never underestimate what you can learn if you have a passion or an inquisitive mind for the topic."

Give it a read: https://bit.ly/3W7IufS

10/07/2025

Combined with regular antiretroviral therapy, could fostemsavir have beneficial effects on the health of people living with HIV?

A team at Université de Montréal, including the CTN+'s Dr. Madeline Durand, will be investigating this very question with the RESTART trial this fall.

Learn more:
https://bit.ly/48P8SCv

10/03/2025

“CMV is the most common virus that no one's heard of,” said Dr. Jason Brophy, one of the scientists behind Ontario's newborn CMV screening program, the first of its kind in Canada.

He discusses the impact of CMV on , the program's effectiveness six years in, and next steps.

Come learn about this important element of public health:
https://bit.ly/4pPsjBg

10/01/2025

Are you passionate about supporting your peers through leadership?
Do you want to strengthen your skills by guiding community events, collaborating, and creating empowering spaces for women?

The BCC3 Study is now recruiting women living with HIV in British Columbia to become Community Facilitators.

Facilitators will play a key role in leading knowledge-sharing events across the region.

These events provide opportunities to exchange lived experiences, build supportive networks, and make health information more accessible.

As a facilitator, you will:
Lead and guide conversations at local events.
Collaborate with researchers and community members.
Help shape how health knowledge is shared
Receive training and be compensated for your leadership and time.

You are eligible if you:
1. Identify as a woman
2. Are living with HIV
3. Live in British Columbia

Interested in applying? Fill out our short survey here: https://ubc.ca1.qualtrics.com/jfe/form/SV_0kTNSLoTB0GTZoq

09/12/2025

Community has significantly shaped the global HIV response since 1981, advocating for government action, increased representation in clinical trials, and access to treatments.

The CTN+'s Community Advisory Committee (CAC) carries on this tradition by embedding individuals from across Canada living with HIV and/or STBBIs into study review and .

Community Leadership Team Co-Chair Rico Mandarino says, "The role of the CAC goes far beyond protocol review. They ensure marginalized voices are included, heard, and respected throughout the research process."

Learn more about the CAC and how to join:
https://bit.ly/4ghh1RX

Address

178/1081 Burrard Street
Vancouver, BC
V6Z1Y6

Website

http://www.hivnet.ubc.ca/

Alerts

Be the first to know and let us send you an email when CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CIHR Pan-Canadian Network for HIV and STBBI Clinical Trials Research:

Want your practice to be the top-listed Clinic in Vancouver?